pantoprazole has been researched along with Hyponatremia in 5 studies
Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.
Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
"The study was designed to detect novel Adverse Events (AEs) of pantoprazole by disproportionality analysis in the FDA (Food and Drug Administration) database of Adverse Event Reporting System (FAERS) using Data Mining Algorithms (DMAs)." | 5.91 | Pantoprazole associated dyspepsia hypocalcemia and hyponatremia: A disproportionality analysis in FDA adverse event reporting system (FAERS) database. ( Eswaran, M; Kulkarni, AR; Nair, HP; Subeesh, V, 2023) |
"Omeprazole was replaced by ranitidine after which his serum sodium levels normalized to 135 mmol/L." | 5.56 | Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report. ( Logtenberg, SJJ; Tobé, TJM; van der Zalm, IJB, 2020) |
"With the exception of lansoprazole, this study suggests an association between any newly initiated PPI-treatment and hospitalization due to hyponatremia." | 3.91 | Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study. ( Calissendorff, J; Falhammar, H; Lindh, JD; Mannheimer, B; Nathanson, D; Skov, J, 2019) |
"The study was designed to detect novel Adverse Events (AEs) of pantoprazole by disproportionality analysis in the FDA (Food and Drug Administration) database of Adverse Event Reporting System (FAERS) using Data Mining Algorithms (DMAs)." | 1.91 | Pantoprazole associated dyspepsia hypocalcemia and hyponatremia: A disproportionality analysis in FDA adverse event reporting system (FAERS) database. ( Eswaran, M; Kulkarni, AR; Nair, HP; Subeesh, V, 2023) |
"Omeprazole was replaced by ranitidine after which his serum sodium levels normalized to 135 mmol/L." | 1.56 | Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report. ( Logtenberg, SJJ; Tobé, TJM; van der Zalm, IJB, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Nair, HP | 1 |
Kulkarni, AR | 1 |
Eswaran, M | 1 |
Subeesh, V | 1 |
van der Zalm, IJB | 1 |
Tobé, TJM | 1 |
Logtenberg, SJJ | 1 |
Falhammar, H | 1 |
Lindh, JD | 1 |
Calissendorff, J | 1 |
Skov, J | 1 |
Nathanson, D | 1 |
Mannheimer, B | 1 |
Naharcý, MI | 1 |
Cintosun, U | 1 |
Ozturk, A | 1 |
Bozoglu, E | 1 |
Doruk, H | 1 |
Hamilton, DV | 1 |
Lewis, HR | 1 |
5 other studies available for pantoprazole and Hyponatremia
Article | Year |
---|---|
Pantoprazole associated dyspepsia hypocalcemia and hyponatremia: A disproportionality analysis in FDA adverse event reporting system (FAERS) database.
Topics: Adverse Drug Reaction Reporting Systems; Drug-Related Side Effects and Adverse Reactions; Dyspepsia; | 2023 |
Omeprazole-induced and pantoprazole-induced asymptomatic hyponatremia: a case report.
Topics: Aged; Asymptomatic Diseases; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Omeprazole; Pan | 2020 |
Associations of proton pump inhibitors and hospitalization due to hyponatremia: A population-based case-control study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Esomeprazole; Female; Hospitalization; Humans; Hyponatre | 2019 |
Pantoprazole sodium-induced hyponatremia in a frail elderly adult.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged, 80 and over; Dose-Response Relationship, Drug; Frail | 2014 |
A rare cause of hyponatraemia?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Humans; Hyponatremia; Male; Pantoprazole; Proton Pump | 2009 |